Luspatercept May Prolong Life in Low-Risk MDS ...Middle East

Medscape - News
Luspatercept May Prolong Life in Low-Risk MDS
Updated, longer-term results from the COMMANDS trial show a promising trend toward improved overall survival with luspatercept vs epoetin alfa, in addition to transfusion independence benefits. Medscape Medical News

Hence then, the article about luspatercept may prolong life in low risk mds was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Luspatercept May Prolong Life in Low-Risk MDS )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News